Holen Sie sich die Stockscreener-App
44.02
3.18%
-1.3001
Finanzdaten der Enliven Therapeutics Inc-Aktie (ELVN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
36.62%
34.28
|
25.10 | - | 31.69 | 26.90 |
| Operating Income/Loss |
36.62%
-34.28
|
-25.10 | - | -31.69 | -26.90 |
| Nonoperating Income/Loss |
6.67%
4.618
|
4.948 | - | 3.149 | 3.716 |
| Income/Loss From Continuing Operations Before Tax |
47.25%
-29.67
|
-20.15 | -25.34 | -28.54 | -23.18 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
47.25%
-29.67
|
-20.15 | -25.34 | -28.54 | -23.18 |
|
Net Income/Loss
|
47.25%
-29.67
|
-20.15 | -25.34 | -28.54 | -23.18 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
96.99%
1.8701
|
62.09 | - | 50.05 | 0.9354 |
| Diluted Average Shares |
96.99%
1.8701
|
62.09 | - | 50.05 | 0.9354 |
| Basic Earnings Per Share |
50.00%
-0.48
|
-0.32 | - | -0.57 | -0.46 |
| Diluted Earnings Per Share |
50.00%
-0.48
|
-0.32 | - | -0.57 | -0.46 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):